a game show style scene of people answering questions

Test Your Knowledge about NMO!

How much do you know about NMO? We're about to find out! Answer the six questions below and then see how you did.

1. Neuromyelitis optica spectrum disorder is what type of condition?

  1. Inflammatory
  2. Rare
  3. Disease of the nervous system
  4. Chronic
  5. All of the above

2. How many people are affected by NMO worldwide?

  1. 1 to 10 per 15,0000 people
  2. 1 to 10 per 50,000 people
  3. 1 to 10 per 100,000 people
  4. 1 in 6 billion people

3. Common symptoms of NMO include:

  1. Vision issues
  2. Paralysis
  3. Pain
  4. Nausea and vomiting
  5. Bowel issues
  6. All of the above

4. True of false: Living with NMO means you can no longer exercise

5. Treatments for NMO include:

  1. Steroids
  2. Chemotherapy
  3. Plasma exchange
  4. Biologics
  5. 1,3, and 4
  6. All of the above

6. Common comorbidities of NMO include:

  1. Lupus
  2. Mental health problems
  3. Memory and attention problems
  4. Other autoimmune conditions
  5. Fatigue
  6. All of the above

And the answers are...

  1. 5
  2. 3
  3. 6
  4. False
  5. 5
  6. 6

How many did you get right?

0-1: Maybe it’s time to brush up on your neuromyelitis optica knowledge. Start with learning the basics of NMO.
2-3: You know a bit, but there’s still lots to learn! Maybe try reading up on how NMO is diagnosed.
4-5: Not bad! It sounds like you’re ready to learn the nuances of living with NMO. Check out this article on common myths and misconceptions.
6-7: Pro-status! You clearly have some experience with NMO. Are you interested in sharing your experience with others so they can learn more? Tell us about your journey.

By providing your email address, you are agreeing to our privacy policy. We never sell or share your email address.

More on this topic

This article represents the opinions, thoughts, and experiences of the author; none of this content has been paid for by any advertiser. The Neuromyelitis-Optica.net team does not recommend or endorse any products or treatments discussed herein. Learn more about how we maintain editorial integrity here.

Join the conversation

or create an account to comment.